It can also inhibit cell viability via the AMPK-mediated PLK-2 (Polo-like kinase 2, a serine/threonine-protein kinase) pathway to inhibit the growth of the human breast cancer cell line MCF-7 [165]. This evidence concerns the gene PLK2 and breast carcinoma.